China pharma holdings, inc. reports fiscal year 2020 financial results

Haikou city, china , march 26, 2021 /prnewswire/ -- china pharma holdings, inc. (nyse american: cphi)  ("china pharma," the "company" or "we"), an nyse american-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in china, today announced financial results for the fiscal year ended december 31, 20 20 . full year highlights revenue was both $10.9 million in fiscal year 2020 and 2019 , respectively ; gross margin was 1 8.0 % in fiscal year 20 20 , compared to 1 3.6 % in fiscal year 201 9; loss from operations was $2 .6 million in fiscal year 20 20 compared to $ 2 0.4 million in fiscal year 201 9 , which represented a n improvement of $ 17.8 million; net loss was $2 .9 million in fiscal year 20 20 compared to $ 20.7 million in fiscal year 201 9.
CPHI Ratings Summary
CPHI Quant Ranking